Tag-array based HPV genotyping by competitive hybridization and extension.

A method is described for HPV genotyping based on multiplex competitive hybridization (MUCH) combined with apyrase mediated allele-specific extension (AMASE). Two type-specific oligonucleotides were designed for each of the 23 investigated HPV types and directed towards two highly inter-type heterogeneous regions. The type-specific oligonucleotides were allowed to compete in the hybridization to an immobilized template resulting in a highly specific hybridization process. To increase further the specificity, a second step of type discrimination was used in which specific extension of 3'-termini matched oligonucleotides was performed. The 46 type-specific oligonucleotides each had a unique tag sequence to allow detection via an array of oligonucleotides complementary to the tags. To evaluate the genotyping assay, a total of 92 HPV positive samples were tested in this study. Twelve had double infections and five had three to five coexisting HPV types. The results show that MUCH-AMASE can readily detect multiple infections, whereas conventional dideoxy sequencing resulted in ambiguous sequence. Four samples with three to five genotypes detected were cloned and individual clones were sequenced. The cloning procedure verified the MUCH-AMASE results with indications that we can find minor infections (<2% relative amounts). We can thus conclude that the developed assay is highly sensitive, with improved throughput and with excellent possibility to detect multiple infections.

[1]  F. Wiklund,et al.  Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. , 1999, The New England journal of medicine.

[2]  L. Peltonen,et al.  A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays. , 2000, Genome research.

[3]  C. Levenson,et al.  Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. , 1990, Nucleic acids research.

[4]  R. Mcglennen,et al.  Low-density addressable array for the detection and typing of the human papillomavirus. , 2004, Diagnostic microbiology and infectious disease.

[5]  C. Peyton,et al.  Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. , 1994, The Journal of infectious diseases.

[6]  David R. Scott,et al.  Improved Amplification of Genital Human Papillomaviruses , 2000, Journal of Clinical Microbiology.

[7]  Baback Gharizadeh,et al.  Typing of Human Papillomavirus by Pyrosequencing , 2001, Laboratory Investigation.

[8]  H. Cubie,et al.  Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population , 2003, Journal of clinical pathology.

[9]  Jonas Blomberg,et al.  Development of broadly targeted human endogenous gammaretroviral pol-based real time PCRs Quantitation of RNA expression in human tissues. , 2005, Journal of virological methods.

[10]  G L Andersen,et al.  Sequence-specific identification of 18 pathogenic microorganisms using microarray technology. , 2002, Molecular and cellular probes.

[11]  R. H. Newman,et al.  The virulence of British isolates of bovid herpesvirus 1 in relationship to viral genotype. , 1991, British Veterinary Journal.

[12]  J. Jekel,et al.  Epidemiology, Biostatistics and Preventive Medicine , 1996 .

[13]  David R. Scott,et al.  Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens , 1997, Journal of clinical microbiology.

[14]  J. Day,et al.  Nucleotide analogs facilitate base conversion with 3' mismatch primers. , 1999, Nucleic acids research.

[15]  J. Lundeberg,et al.  Microarray-based AMASE as a novel approach for mutation detection. , 2004, Mutation research.

[16]  K. Cooper,et al.  Human papillomavirus integration: detection by in situ hybridization and potential clinical application , 2004, The Journal of pathology.

[17]  N. Arnheim,et al.  Extension of base mispairs by Taq DNA polymerase: implications for single nucleotide discrimination in PCR. , 1992, Nucleic acids research.

[18]  J. Odeberg,et al.  SNP typing by apyrase-mediated allele-specific primer extension on DNA microarrays. , 2002, Nucleic acids research.

[19]  A. Olshan,et al.  Human Papillomavirus and head and neck cancer: Epidemiology and molecular biology , 1998, Head & neck.

[20]  R. S. Shmookler Reis,et al.  Discrimination of primer 3'-nucleotide mismatch by taq DNA polymerase during polymerase chain reaction. , 2000, Analytical biochemistry.

[21]  R. A. Hubbard,et al.  Human papillomavirus testing methods. , 2009, Archives of pathology & laboratory medicine.

[22]  J. Miller,et al.  Abortifacient property of bovine herpesvirus type 1 isolates that represent three subtypes determined by restriction endonuclease analysis of viral DNA. , 1991, American journal of veterinary research.

[23]  Torbjörn Gräslund,et al.  Integrated strategy for selective expanded bed ion-exchange adsorption and site-specific protein processing using gene fusion technology. , 2002, Journal of biotechnology.

[24]  P. Nilsson,et al.  Escherichia coli single‐stranded DNA‐binding protein, a molecular tool for improved sequence quality in pyrosequencing , 2002, Electrophoresis.

[25]  K. Bieńkowska-Szewczyk,et al.  Epitopes on glycoprotein C of bovine herpesvirus-1 (BHV-1) that allow differentiation between BHV-1.1 and BHV-1.2 strains. , 1999, The Journal of general virology.

[26]  C Summers,et al.  Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). , 1989, Nucleic acids research.

[27]  J. A. Kaan,et al.  Intermethod variation in detection of human papillomavirus DNA in cervical smears , 1995, Journal of clinical microbiology.

[28]  J. T. Oirschot,et al.  Bovine herpesvirus 1 in semen of bulls and the risk of transmission: A brief review , 1995 .

[29]  R. Temple.  Implications of effects in placebo groups. , 2003, Journal of the National Cancer Institute.

[30]  W. Quint,et al.  Molecular detection and genotyping of human papillomavirus , 2001, Expert review of molecular diagnostics.

[31]  K. Lindblad-Toh,et al.  SBE-TAGS: an array-based method for efficient single-nucleotide polymorphism genotyping. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Joakim Lundeberg,et al.  Viral and microbial genotyping by a combination of multiplex competitive hybridization and specific extension followed by hybridization to generic tag arrays. , 2003, Nucleic acids research.

[33]  M. Schiffman,et al.  Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. , 2003, Journal of the National Cancer Institute.

[34]  J. Odeberg,et al.  Genotyping by apyrase-mediated allele-specific extension. , 2001, Nucleic acids research.

[35]  J. Day,et al.  Nucleotide analogs and new buffers improve a generalized method to enrich for low abundance mutations. , 1999, Nucleic acids research.

[36]  J. H. Kim,et al.  Human papillomavirus genotyping by the DNA chip in the cervical neoplasia. , 2004, DNA and cell biology.

[37]  Claude Fauquet,et al.  Classification of papillomaviruses. , 2004, Virology.

[38]  J. Derisi,et al.  Microarray-based detection and genotyping of viral pathogens , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. P. Fodor,et al.  Blocks of Limited Haplotype Diversity Revealed by High-Resolution Scanning of Human Chromosome 21 , 2001, Science.

[40]  P. Roehe,et al.  Comparative pathogenicity of bovine herpesvirus 1 (BHV-1) subtypes 1 (BHV-1.1) and 2a (BHV-1.2a) , 2004 .